• 1. Synthesis of the pyridine analogues of phthalide
  William R. Ashcroft,Michael G. Beal,John A. Joule J. Chem. Soc. Perkin Trans. 1 1981 3012

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Introducing Furo3,4-BPyridin-5(7h)-One (CAS No: 5657-51-2): A Compound with Promising Applications in Modern Chemical and Pharmaceutical Research

Furo3,4-BPyridin-5(7h)-One, identified by its unique Chemical Abstracts Service Number (CAS No: 5657-51-2), is a heterocyclic compound that has garnered significant attention in the fields of medicinal chemistry and chemical biology. This compound belongs to the class of fused pyridine derivatives, characterized by its structural integration of a furan ring with a pyridine moiety. The presence of these functional groups imparts distinct electronic and steric properties, making it a versatile scaffold for the development of novel pharmaceutical agents and biochemical probes.

The structure of Furo3,4-BPyridin-5(7h)-One features a five-membered oxygen-containing heterocycle (furan) fused to a six-membered nitrogen-containing heterocycle (pyridine). This unique arrangement creates a system with rich electronic interactions, which can be exploited for various chemical modifications. The compound’s molecular framework allows for selective functionalization at multiple positions, including the 3-position of the furan ring, the 4-position of the pyridine ring, and the 5(7h)-position, which is particularly relevant for further derivatization.

Recent advancements in computational chemistry have highlighted the potential applications of Furo3,4-BPyridin-5(7h)-One in drug design. Molecular modeling studies suggest that this compound exhibits favorable interactions with biological targets, particularly those involved in inflammatory and metabolic pathways. The furan-pyridine core is known to mimic natural bioactive scaffolds found in many pharmacologically active molecules, enhancing its suitability as a lead compound in medicinal chemistry.

In the realm of biochemical research, Furo3,4-BPyridin-5(7h)-One has been investigated for its role as a modulator of enzyme activity. Preliminary studies indicate that derivatives of this compound may exhibit inhibitory effects on certain enzymes implicated in diseases such as cancer and neurodegeneration. The steric and electronic properties of the molecule allow it to bind to specific enzyme pockets with high affinity, potentially leading to the development of targeted therapeutic agents.

The pharmaceutical industry has shown interest in Furo3,4-BPyridin-5(7h)-One due to its structural versatility and biological relevance. Researchers are exploring its potential as an intermediate in synthesizing novel drugs that address unmet medical needs. The compound’s ability to undergo diverse chemical transformations makes it an attractive candidate for library synthesis programs aimed at identifying new bioactive molecules.

Moreover, Furo3,4-BPyridin-5(7h)-One has found utility in chemical biology as a tool for studying protein-ligand interactions. Its well-defined structure and predictable reactivity make it an excellent candidate for use in high-throughput screening assays. By leveraging this compound, scientists can rapidly identify new binding partners and understand their mechanisms of action, contributing to a deeper understanding of cellular processes.

Recent publications have demonstrated the synthetic utility of Furo3,4-BPyridin-5(7h)-One in constructing more complex molecular architectures. Researchers have employed this compound as a key intermediate in multi-step synthetic routes, leading to the development of novel heterocyclic derivatives with enhanced pharmacological properties. These studies underscore the importance of Furo3,4-BPyridin-5(7h)-One as a building block in modern synthetic organic chemistry.

The toxicological profile of Furo3,4-BPyridin-5(7h)-One has also been examined to ensure its safety for laboratory use. Initial toxicity assessments suggest that the compound exhibits low acute toxicity when handled under standard conditions. However, further studies are required to fully characterize its long-term effects and potential metabolic pathways. These findings are crucial for guiding its safe application in both academic and industrial settings.

In conclusion, Furo3,4-BPyridin-5(7h)-One (CAS No: 5657-51-2) represents a promising compound with diverse applications across chemical biology and pharmaceutical research. Its unique structural features and biological relevance make it an invaluable tool for drug discovery and mechanistic studies. As research continues to uncover new possibilities for this molecule, it is likely to play an increasingly significant role in advancing our understanding of complex biological systems.

• 1721-26-2(Ethyl 2-methylnicotinate)
• 605-38-9(2,3-dimethyl pyridine-2,3-dicarboxylate)
• 159755-62-1(2-Pyridinecarboxylic acid, 3-formyl-, ethyl ester)
• 4733-69-1(5H,7H-furo3,4-bpyridin-7-one)
• 1721-13-7(ethyl 2,6-dimethylpyridine-3-carboxylate)
• 499-83-2(Pyridine-2,6-dicarboxylic acid)
• 2050-22-8(Diethyl pyridine-2,3-dicarboxylate)
• 699-98-9(5H,7H-furo[3,4-b]pyridine-5,7-dione)
• 59-67-6(Niacin)
• 24195-07-1(2-(methoxycarbonyl)pyridine-3-carboxylic acid)